Hangzhou Sciwind Biosciences Co., Ltd.
Clinical trials sponsored by Hangzhou Sciwind Biosciences Co., Ltd., explained in plain language.
-
Weekly injection trial aims to ease sleep apnea and promote weight loss
Disease control Not yet recruitingThis study is testing whether weekly injections of an investigational drug called XW003 can help reduce breathing pauses during sleep and lower body weight in obese adults who have obstructive sleep apnea. Participants will receive either XW003 or a placebo injection for up to 48…
Phase: PHASE3 • Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New weekly injection aims to tame sleep apnea and shed pounds
Disease control Not yet recruitingThis study is testing whether a new weekly injection called XW003 can help people who have both obesity and obstructive sleep apnea (OSA). It will compare the injection to a placebo (dummy treatment) in 140 adults who do not use a standard breathing machine (PAP therapy) for thei…
Phase: PHASE3 • Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC